Japan approved the world's first stem-cell treatment for Parkinson's

Parkinson's steals movement as the brain runs out of dopamine-making cells. Japan cleared Amchepry, which transplants lab-grown dopamine cell precursors into the brain — the first commercial stem-cell therapy for the disease, with patients already improving in trials.